METROPOLIS.NS
METROPOLIS.NS
INE112L01020
METROPOLIS HEALTHCARE LTD
Loading chart...

Company Profile

Metropolis Healthcare Limited, together with its subsidiaries, provides pathology and related healthcare services in India and internationally. The company offers routine and specialised pathology tests; advanced diagnostics, including genetic, molecular, and cytogenetic testing; preventive healthcare packages and corporate wellness screening; clinical trial research, hospital lab management, and home collection services; radiology services, including X-ray, sonography and ECG; and next-generation sequencing services. It also provides diagnostic services for oncology, chronic and infectious diseases, gastroenterology, neurology, nephrology, and women and child health, as well as various health checkup and laboratory services. The company serves a range of customers, including direct-to-consumer diagnostics through patient service centers, mobile app, website, and home collection; partnerships with standalone labs, hospital chains, and diagnostic networks; and institutional clients, such as corporates, government bodies, and hospital lab management services. Metropolis Healthcare Limited was founded in 1980 and is headquartered in Mumbai, India.

Related stocks

SYNGENE.NS
SYNGENE.NS • India
SYNGENE INTERNATIONAL LTD
347.4 INR
1.44B USD 1Y -45.1%
VIJAYA.NS
VIJAYA.NS • India
VIJAYA DIAGNOSTIC CEN LTD
1,436.6 INR
1.53B USD 1Y +44.5%
THYROCARE.BO
THYROCARE.BO • India
Thyrocare Technologies Limited
499 INR
820.66M USD 1Y +22%
SAILIFE.NS
SAILIFE.NS • India
SAI LIFE SCIENCES LIMITED
1,487.9 INR
3.27B USD 1Y +74.7%
LALPATHLAB.NS
LALPATHLAB.NS • India
DR. LAL PATH LABS LTD.
1,933.6 INR
3.34B USD 1Y +23.3%
4544.T
4544.T • Japan
H.U. GROUP HLDGS INC
3,580 JPY
1.23B USD 1Y -4%
300406.SZ
300406.SZ • China
BSBE
12.14 CNY
1.06B USD 1Y -9.7%
300685.SZ
300685.SZ • China
AMOYDX
20.3 CNY
1.18B USD 1Y -11.6%

Key Metrics & Overview

Detailed metrics & financial data of the company

Company Profile
5 Metrics

🛡️ Risk & Structural Analysis

Multi-Factor Risk Model & Market Data

7/7 Very High
5Y Volatility
33.4% p.a.
Max Drawdown (5Y)
-65.5%
Sharpe Ratio (5Y)
-0.25
Beta Factor
0.20
Size Class
Mega Cap
Notes & Warnings
Single Stock Risk: Investing in an individual stock carries full company and insolvency risk (no fund diversification).
Exemplary balance sheet strength: Very solid ratio of equity to debt.
🔴 High valuation risk: Avg P/E of 54.5 (Elevated multiple compression risk)
Structurally High Volatility: Above-average fluctuations persist across 5 to 10 years (33.4% p.a.).
Historical Stress Test: Maximum peak-to-trough drawdown of -65.5% in the extended horizon.
ende